XM does not provide services to residents of the United States of America.
S
S

Scor

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Scor jumps after 'considerable' beat on Q3 solvency

BUZZ-Scor jumps after 'considerable' beat on Q3 solvency ** Shares in Scor SCOR.PA jump 7.7%, topping the SBF 120 .SBF120 index, boosted the French reinsurance company's better-than-expected solvency, completed review of life business ** Scor's group solvency ratio stand at 203% as of September 30, which J.P.Morgan says is "meaningfully ahead of consensus of 191%" ** "Although SCOR's profitability is materially worse than expected ...
S

Scor Q3 Insurance Revenue Down At EUR 3.94 Billion

BRIEF-Scor Q3 Insurance Revenue Down At EUR 3.94 Billion Nov 14 (Reuters) - Scor SE SCOR.PA : Q3 INSURANCE REVENUE EUR 3.94 BILLION VERSUS EUR 4.24 BILLION YEAR AGO Q3 NET LOSS EUR -117 MILLION VERSUS PROFIT EUR 147 MILLION YEAR AGO Q3 OPERATING LOSS EUR -53 MILLION VERSUS PROFIT EUR 257 MILLION YEAR AGO GROUP SOLVENCY RATIO AT 203% AS OF SEPTEMBER
S

Scor Increases Offer Price for MRM To EUR 35.50 Per Share

BRIEF-Scor Increases Offer Price for MRM To EUR 35.50 Per Share Nov 7 (Reuters) - Scor SE SCOR.PA : SAID ON WEDNESDAY IT ADJUSTED PRICE FOR PROPOSED PUBLIC OFFER FOR MRM HAS DECIDED TO ROUND UP TO EUR 35.50 PER MRM SHARE PROPOSED PRICE FOR SIMPLIFIED PUBLIC TENDER OFFER AND INDEMNIFICATION OF POTENTIAL SQUEEZE OUT PRICE INCREASE DOES NOT IMPACT IN
S

European reinsurers rise as hurricane losses appear less than feared

BUZZ-European reinsurers rise as hurricane losses appear less than feared ** Shares in European reinsurers rise as insured losses from hurricanes Helene and Milton in the U.S. may not be as high as originally feared ** "The latest update signals a more southernly direction, and our best guess for insured losses is now around the $50bn mark," Citi says in a note ** "We moved away from the most catastrophic scenarios.
H
S
S
G

Scor In Talks With Albin Michel For The Sale Of Humensis

BRIEF-Scor In Talks With Albin Michel For The Sale Of Humensis Oct 9 (Reuters) - Scor SE SCOR.PA : HAS ENTERED IN EXCLUSIVE NEGOTIATIONS WITH ALBIN MICHEL FOR THE SALE OF HUMENSIS - SPOKESPERSON Further company coverage: SCOR.PA (Gdansk Newsroom)
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.